WADA joins UCI to ban Tramadol use in competition after Quintana tested positive in the Tour de France

The World Anti-Doping Agency (WADA) has until recently not considered Tramadol a substance that can lead to a suspension whilst in competition, but that is about to change as it joins the UCI in the decision to ultimately ban the substance from any in-competition use, with the consequence of suspensions confirmed.

"Research studies funded by WADA have also confirmed the potential for tramadol to enhance physical performance," WADA said in a recent press release. This will mean the substance will no longer be permitted to use in competition and can much more easily lead to suspensions of the riders who may use it. Whilst it was already considered a banned substance by the UCI, WADA have only now made the call.

This came after studies funded by WADA proved the great possibility that the substance may be performance enhancing in endurance sports, aswell as the danger of addiction to athletes. The news come in the wake of Nairo Quintana having tested positive for the substance twice during the Tour de France, which has led to his results being nullified, but did not lead to a suspension or ban however.

The Colombian rider is currently working on his defense in the came, for over a month. The ban will only be introduced in 2024 however, WADA justifies the delay to give the teams and riders time to adapt to the new rules and avoid. More specifically, "to allow the communication of the implications of it."